Eddy Rommel
Chief Executive Officer at Rommel Consulting Partners
Profile
Eddy Rommel is the founder of Rommel Consulting Partners, which was founded in 2002.
He is currently a member of the Belgian Council for Laboratory Animal Science.
Dr. Rommel was formerly the Chairman of the European Federation of Pharmaceutical Industries & Assns.
He was also an Associated Director at GlaxoSmithKline Biologicals NV from 1988 to 2002.
Dr. Rommel worked as a Research Assistant at the University of Liege and was Vice President-PreClinical Development at PROMETHERA Biosciences SA from 2009 to 2012.
Dr. Rommel has a graduate and doctorate degree from the University of Liege and an undergraduate degree from the University of Lyon.
Eddy Rommel active positions
| Companies | Position | Start |
|---|---|---|
| Rommel Consulting Partners | Chief Executive Officer | 2001-12-31 |
| Belgian Council for Laboratory Animal Science | Corporate Officer/Principal | - |
Former positions of Eddy Rommel
| Companies | Position | End |
|---|---|---|
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Corporate Officer/Principal | 2012-02-29 |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Corporate Officer/Principal | 2001-12-31 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Chairman | - |
| University of Liege | Corporate Officer/Principal | - |
Training of Eddy Rommel
| University of Liege | Doctorate Degree |
| University of Lyon | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Health Technology |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
| Rommel Consulting Partners | |
| Belgian Council for Laboratory Animal Science |
- Stock Market
- Insiders
- Eddy Rommel
